抗肿瘤药物盐酸埃罗替尼的合成  

Synthesis of Antineoplastic Agent Erlotinib Hydrochloride

作　　者：陆峥 高志伟 Lu Zheng;Gao Zhi-wei

机构地区：[1]浙江理工大学理学院化学系,浙江杭州310018 [2]浙江凯普化工有限公司,浙江嘉兴314201

出　　处：《化工设计通讯》2018年第10期192-192,共1页Chemical Engineering Design Communications

摘　　要：盐酸埃罗替尼是一种4-苯胺基喹唑啉类的小分子化合物,主要以蛋白酪氨酸激酶为中心的一种抗肿瘤药物,对治疗非小细胞的肺癌、胰腺癌等有重要作用。针对抗肿瘤药物盐酸埃罗替尼的合成进行分析,对盐酸埃罗替尼合成工艺进行分析,旨在探讨研究一条高回报、低成本的商业化盐酸埃罗替尼合成道路。Erotinil hydrochloride is a small molecule compound of 4-aniline quinazoline,which is mainly an antitumor drug centered on protein tyrosine kinase,and plays an important role in the treatment of non-small cell lung cancer,pancreatic cancer and so on.In this paper,the synthesis of the anticancer drug erlotinib hydrochloride was analyzed,and the synthetic process of erlotinib hydrochloride was analyzed,aiming to explore a commercial synthetic route of erlotinib hydrochloride with high return and low cost.

关 键 词：抗肿瘤 药物 盐酸埃罗替尼 

分 类 号：TQ463.5[化学工程—制药化工]